Maiden Pharma has got a clean chit from the Central Government. In the Rajya Sabha on Thursday, the government made it clear that the samples of Medan Pharma’s cough syrup have been found to be of quality. After this, on Friday i.e. today, the Drug Controller of India has written a letter to WHO for prematurely putting Indian Maiden Pharma’s syrup in the dock for the deaths in Gambia.

) Drug Controller General of India wrote a letter to WHO: Country’s Drug Controller General of India WHO Wrote a strongly worded letter to In a strongly worded letter, the Drug Controller General of India told WHO’s Director of Regulation and Prequalification, Rogerio Gaspar, that all samples of Medan Pharma’s products were found to comply with the guidelines.

Central Government gave clean chit: Significantly, drinking so-called Indian cough syrup in the African country Gambia In the case of death of children, yesterday i.e. on Thursday, the government Gave clean chit to Medan Pharma company. Responding in the Rajya Sabha, the Central Government said that no flaw has been found in the investigation of cough syrup. It was told in the center that an inquiry committee was formed under the chairmanship of Dr. YK Gupta on behalf of the Ministry of Health to investigate the syrup of Medan Pharma Company. The committee in its report said that there is no deficiency in the quality of the syrup.

WHO had issued a medical alert: Significantly, in the African country Gambia After the death of the children, four cuffs of Medan Pharmaceuticals were banned by the World Health Organization. WHO had issued a medical alert against the syrup. The WHO said that contaminated and low-quality cough syrup from Maiden Pharmaceuticals Ltd may be responsible for the deaths of children in The Gambia. After which the Haryana government took a big step and banned the production of cough syrup of Maiden Pharmaceuticals Limited.

WhoCough SyrupDGCIPublished Date

Fri, Dec 16, 2022, 2: 04 PM IST